2021 Gilead Sciences Mid-Year Review-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
2020 Cronos Group Performance, Capabilities, Goals and Strategies
US$ 950.00
March 2020
-
Bayer: 2017-2021 Global Animal Health Market Segment Forecasts and Company's Strategic Assessment
US$ 750.00
December 2017
-
2019 Pharmaceutical Competitive Intelligence: Jazz Pharmaceuticals Performance, Capabilities, Goals and Strategies
US$ 950.00
February 2019
-
2021 Curaleaf Mid-Year Review-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
US$ 750.00
June 2021
-
2018-2022 Animal Health: Market Segment Forecasts, and Leading Supplier Strategies, Marketing Tactics, and Technological Know-How
US$ 4,850.00
January 2018
110 pages
